[MNPR] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[MNPR] Monopar Therapeutics Inc.
Announcement Date
12-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 18.76%
YoY- -15.00%
Quarter Report
MNPR's Result
MNPR's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -1,446 -1,091 -1,207 -736 -906 -1,376 -962 31.25%
Tax -1,464 -1,136 -1,225 -759 -932 -1,407 -72 646.33%
NP -1,446 -1,091 -1,207 -736 -906 -1,376 -890 38.24%
Tax Rate - - - - - - - -
Total Cost 1,446 1,091 1,207 736 906 1,376 890 38.24%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -0.14 -0.10 -0.11 -0.07 -0.09 -0.13 -0.09 34.28%
EPS Diluted -0.14 -0.10 -0.11 -0.07 -0.09 -0.13 -0.09 34.28%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.